1-(4-Methylsulfonyl-2-nitrophenyl)piperazine, 95.0%, 1g

1H-INDOLE-1-CARBOXYLIC ACID, 5-(BROMOMETHYL)-, 1,1-DIMETHYLETHYL ESTER, 95%, 500mg

1,3-Dimethyl-1H-benzo[d]imidazol-3-ium iodide, 95.0%, 1g

4,5-Dichlorothiophene-2-carboxylic acid, 95.0%, 1g

(3S,4R)-1-Methyl-pyrrolidine-3,4-dicarboxylic acid dimethyl ester racemate, 95.0%, 1g

Methyl 4-bromo-3,5-dihydroxybenzoate, 95.0%, 250mg

1-(2,2-Difluoroethyl)-1H-pyrazol-4-amine, 97%, 500mg

Narrow mouth bottle aluminium with UN approval, 1250 ml, 1 Piece

4-(3-(Dimethylamino)propoxy)benzaldehyde, 95.0%, 1g

5-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 95%, 25g

6-Fluoro-2H-1,4-benzoxazin-3(4H)-one, 95.0%, 1g

4-((Tetrahydrofuran-3-yl)oxy)aniline, 97%, 250mg

Myristic acid isopropyl ester, min. 92%, extra pure, 1 l, glass packaging